These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 9714415

  • 1. Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.
    Aries SP, Weyrich K, Schaaf B, Hansen F, Dennin RH, Dalhoff K.
    Scand J Immunol; 1998 Jul; 48(1):86-91. PubMed ID: 9714415
    [Abstract] [Full Text] [Related]

  • 2. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B.
    AIDS Res Hum Retroviruses; 2000 Feb 10; 16(3):191-201. PubMed ID: 10710207
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).
    Gougeon ML, Lecoeur H, Sasaki Y.
    Immunol Lett; 1999 Mar 10; 66(1-3):97-103. PubMed ID: 10203040
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
    Sevilya Z, Chorin E, Gal-Garber O, Zelinger E, Turner D, Avidor B, Berke G, Hassin D.
    Front Immunol; 2018 Mar 10; 9():2068. PubMed ID: 30254642
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy.
    Grelli S, Campagna S, Lichtner M, Ricci G, Vella S, Vullo V, Montella F, Di Fabio S, Favalli C, Mastino A, Macchi B.
    AIDS; 2000 May 26; 14(8):939-49. PubMed ID: 10853975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2.
    Regamey N, Harr T, Battegay M, Erb P.
    AIDS Res Hum Retroviruses; 1999 Jun 10; 15(9):803-10. PubMed ID: 10381168
    [Abstract] [Full Text] [Related]

  • 11. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment.
    Briceño O, Pinto-Cardoso S, Rodríguez-Bernabe N, Murakami-Ogasawara A, Reyes-Terán G.
    PLoS One; 2016 Jun 10; 11(11):e0166496. PubMed ID: 27898686
    [Abstract] [Full Text] [Related]

  • 12. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study.
    Moretti S, Alesse E, Di Marzio L, Zazzeroni F, Ruggeri B, Marcellini S, Famularo G, Steinberg SM, Boschini A, Cifone MG, De Simone C.
    Blood; 1998 May 15; 91(10):3817-24. PubMed ID: 9573019
    [Abstract] [Full Text] [Related]

  • 13. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Benito JM, López M, Martín JC, Lozano S, Martínez P, González-Lahoz J, Soriano V.
    AIDS Res Hum Retroviruses; 2002 Dec 10; 18(18):1379-88. PubMed ID: 12487809
    [Abstract] [Full Text] [Related]

  • 14. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 15. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.
    Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Lynch DH, Tschopp J, Angel JB.
    Cell Death Differ; 1999 May 15; 6(5):420-32. PubMed ID: 10381636
    [Abstract] [Full Text] [Related]

  • 16. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.
    AIDS; 2000 May 05; 14(7):761-70. PubMed ID: 10839583
    [Abstract] [Full Text] [Related]

  • 17. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G, Quest Study Group.
    AIDS; 2002 Mar 08; 16(4):589-96. PubMed ID: 11873002
    [Abstract] [Full Text] [Related]

  • 18. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR, Bloch M, Zaunders JJ, Smith D, Cooper DA.
    AIDS; 2000 May 26; 14(8):959-69. PubMed ID: 10853977
    [Abstract] [Full Text] [Related]

  • 19. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T, Imami N, Nelson M, Gazzard BG, Bower M.
    AIDS; 2002 Mar 08; 16(4):531-6. PubMed ID: 11872995
    [Abstract] [Full Text] [Related]

  • 20. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S, Otto SA, Knol GJ, Manting EH, Nanlohy NM, Jansen C, Lange JM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2002 Apr 08; 32(4):1080-9. PubMed ID: 11920575
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.